BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mejias-Aponte CA. Specificity and impact of adrenergic projections to the midbrain dopamine system. Brain Res 2016;1641:258-73. [PMID: 26820641 DOI: 10.1016/j.brainres.2016.01.036] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Solecki WB, Kielbinski M, Wilczkowski M, Zajda K, Karwowska K, Joanna B, Rajfur Z, Przewłocki R. Regulation of cocaine seeking behavior by locus coeruleus noradrenergic activity in the ventral tegmental area is time- and contingency-dependent. Front Neurosci 2022;16:967969. [DOI: 10.3389/fnins.2022.967969] [Reference Citation Analysis]
2 Solecki WB, Kielbinski M, Bernacka J, Gralec K, Klasa A, Pradel K, Rojek-sito K, Przewłocki R. Alpha1-adrenergic receptor blockade in the ventral tegmental area attenuates acquisition of cocaine-induced pavlovian associative learning. Front Behav Neurosci 2022;16:969104. [DOI: 10.3389/fnbeh.2022.969104] [Reference Citation Analysis]
3 Hezemans FH, Wolpe N, O'Callaghan C, Ye R, Rua C, Jones PS, Murley AG, Holland N, Regenthal R, Tsvetanov KA, Barker RA, Williams-Gray CH, Robbins TW, Passamonti L, Rowe JB. Noradrenergic deficits contribute to apathy in Parkinson's disease through the precision of expected outcomes. PLoS Comput Biol 2022;18:e1010079. [PMID: 35533200 DOI: 10.1371/journal.pcbi.1010079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Grinevich VP, Krupitsky EM, Gainetdinov RR, Budygin EA. Linking Ethanol-Addictive Behaviors With Brain Catecholamines: Release Pattern Matters. Front Behav Neurosci 2021;15:795030. [PMID: 34975429 DOI: 10.3389/fnbeh.2021.795030] [Reference Citation Analysis]
5 Mannangatti P, Ragu Varman D, Ramamoorthy S, Jayanthi LD. Neurokinin-1 Antagonism Distinguishes the Role of Norepinephrine Transporter from Dopamine Transporter in Mediating Amphetamine Behaviors. Pharmacology 2021;106:597-605. [PMID: 34515205 DOI: 10.1159/000518033] [Reference Citation Analysis]
6 Brougher J, Sanchez CA, Aziz US, Gove KF, Thorn CA. Vagus Nerve Stimulation Induced Motor Map Plasticity Does Not Require Cortical Dopamine. Front Neurosci 2021;15:693140. [PMID: 34497484 DOI: 10.3389/fnins.2021.693140] [Reference Citation Analysis]
7 Skryabin VY, Vinnikova MA, Komarov SD, Khvan AG. Non-medical Use of Naphazoline (Naphthyzin): Two Case Reports. J Addict Med 2020;14:e267-70. [PMID: 31972770 DOI: 10.1097/ADM.0000000000000617] [Reference Citation Analysis]
8 Cacabelos R, Carrera I, Martínez O, Alejo R, Fernández-Novoa L, Cacabelos P, Corzo L, Rodríguez S, Alcaraz M, Nebril L, Tellado I, Cacabelos N, Pego R, Naidoo V, Carril JC. Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics. Med Res Rev 2021;41:2841-86. [PMID: 34106485 DOI: 10.1002/med.21838] [Reference Citation Analysis]
9 Fukuwada N, Kanno M, Yoshida S, Seki K. Gαq protein signaling in the bed nucleus of the stria terminalis regulate the lipopolysaccharide-induced despair-like behavior in mice. AIMS Neurosci 2020;7:438-58. [PMID: 33263080 DOI: 10.3934/Neuroscience.2020027] [Reference Citation Analysis]
10 Devoto P, Sagheddu C, Santoni M, Flore G, Saba P, Pistis M, Gessa GL. Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex. Front Pharmacol 2020;11:588160. [PMID: 33071798 DOI: 10.3389/fphar.2020.588160] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Gilmiyarova FN, Kolotyeva NA, Kuzmicheva VI, Gusyakova OA, Borodina IA, Baisheva GM, Selezneva IA. [Blood group and human diseases (review of literature).]. Klin Lab Diagn 2020;65:216-21. [PMID: 32227726 DOI: 10.18821/0869-2084-2020-65-4-216-221] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Vena AA, Zandy SL, Cofresí RU, Gonzales RA. Behavioral, neurobiological, and neurochemical mechanisms of ethanol self-administration: A translational review. Pharmacol Ther 2020;212:107573. [PMID: 32437827 DOI: 10.1016/j.pharmthera.2020.107573] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Saganuwan SA. Chemistry and Effects of Brainstem Acting Drugs. Cent Nerv Syst Agents Med Chem 2019;19:180-6. [PMID: 31223094 DOI: 10.2174/1871524919666190620164355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Vaz RL, Chapela D, Coelho JE, Lopes LV, Ferreira JJ, Afonso ND, Sousa S, Outeiro TF. Tapentadol Prevents Motor Impairments in a Mouse Model of Dyskinesia. Neuroscience 2020;424:58-71. [PMID: 31682948 DOI: 10.1016/j.neuroscience.2019.08.046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Bari BA, Chokshi V, Schmidt K. Locus coeruleus-norepinephrine: basic functions and insights into Parkinson's disease. Neural Regen Res 2020;15:1006-13. [PMID: 31823870 DOI: 10.4103/1673-5374.270297] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
16 Solecki WB, Kielbinski M, Karwowska K, Zajda K, Wilczkowski M, Rajfur Z, Przewłocki R. Alpha1-adrenergic receptor blockade in the ventral tegmental area modulates conditional stimulus-induced cocaine seeking. Neuropharmacology 2019;158:107680. [DOI: 10.1016/j.neuropharm.2019.107680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Cools R. Chemistry of the Adaptive Mind: Lessons from Dopamine. Neuron 2019;104:113-31. [DOI: 10.1016/j.neuron.2019.09.035] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
18 Kielbinski M, Bernacka J, Solecki WB. Differential regulation of phasic dopamine release in the forebrain by the VTA noradrenergic receptor signaling. J Neurochem 2019;149:747-59. [PMID: 31001835 DOI: 10.1111/jnc.14706] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
19 Kreiner G, Rafa-Zabłocka K, Barut J, Chmielarz P, Kot M, Bagińska M, Parlato R, Daniel WA, Nalepa I. Stimulation of noradrenergic transmission by reboxetine is beneficial for a mouse model of progressive parkinsonism. Sci Rep 2019;9:5262. [PMID: 30918302 DOI: 10.1038/s41598-019-41756-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
20 Deal AL, Mikhailova MA, Grinevich VP, Weiner JL, Gainetdinov RR, Budygin EA. In vivo voltammetric evidence that locus coeruleus activation predominantly releases norepinephrine in the infralimbic cortex: Effect of acute ethanol. Synapse 2019;73:e22080. [PMID: 30447016 DOI: 10.1002/syn.22080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
21 Pradel K, Blasiak T, Solecki WB. Adrenergic Receptor Agonists’ Modulation of Dopaminergic and Non-dopaminergic Neurons in the Ventral Tegmental Area. Neuroscience 2018;375:119-34. [DOI: 10.1016/j.neuroscience.2017.11.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
22 Zhu M. Noradrenergic Modulation on Dopaminergic Neurons. Neurotox Res 2018;34:848-59. [DOI: 10.1007/s12640-018-9889-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
23 Solecki WB, Szklarczyk K, Pradel K, Kwiatkowska K, Dobrzański G, Przewłocki R. Noradrenergic signaling in the VTA modulates cocaine craving. Addict Biol 2018;23:596-609. [PMID: 28635140 DOI: 10.1111/adb.12514] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
24 Pisk SV, Vuk T, Ivezić E, Jukić I, Bingulac-Popović J, Filipčić I. ABO blood groups and psychiatric disorders: a Croatian study. Blood Transfus 2019;17:66-71. [PMID: 29517969 DOI: 10.2450/2018.0266-17] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Park JW, Bhimani RV, Park J. Noradrenergic Modulation of Dopamine Transmission Evoked by Electrical Stimulation of the Locus Coeruleus in the Rat Brain. ACS Chem Neurosci 2017;8:1913-24. [PMID: 28594540 DOI: 10.1021/acschemneuro.7b00078] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
26 Mokler DJ, Miller CE, Mcgaughy JA. Evidence for a role of corticopetal, noradrenergic systems in the development of executive function. Neurobiology of Learning and Memory 2017;143:94-100. [DOI: 10.1016/j.nlm.2017.02.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
27 Cacabelos R. Parkinson's Disease: From Pathogenesis to Pharmacogenomics. Int J Mol Sci 2017;18:E551. [PMID: 28273839 DOI: 10.3390/ijms18030551] [Cited by in Crossref: 163] [Cited by in F6Publishing: 138] [Article Influence: 32.6] [Reference Citation Analysis]